Article Text
Abstract
Portosystemic encephalopathy commonly occurs in patients with portal hypertension caused by end-stage liver disease or portal vein thrombosis. Congenital extrahepatic portosystemic shunt (CEPS) is an underdiagnosed and treatable condition that can cause encephalopathy and various neuropsychiatric symptoms. We report an unusual case of type 2 CEPS in a 29-year-old woman who presented with progressive myelopathy and fluctuating encephalopathy on a background of congenital cardiac disease. Investigations showed hyperammonaemia, and despite no evidence of portal hypertension on ultrasound imaging, CT scan of abdomen showed a shunt between the mesenteric and left internal iliac veins. Patients with unexplained fluctuating or progressive neuropsychiatric symptoms should have their serum ammonia checked. A raised serum ammonia concentration without known portal hypertension should prompt further investigations for extrahepatic shunts.
- metabolic disease
- neuropsychiatry
- myelopathy
- encephalopathy
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Intrahepatic portosystemic shunts, from prenatal diagnosis to postnatal outcome: a retrospective study
- Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy
- Abernethy malformation and hepatocellular carcinoma: a serious consequence of a rare disease
- Closure of a distal splenorenal shunt as a therapy for refractory hyperammonaemia in setting of neuropsychiatric symptoms
- Plasma lactate concentrations and blood gas values in dogs undergoing surgical attenuation of a single congenital portosystemic shunt
- Pulmonary arteriovenous malformations in a patient with single ventricle and polysplenia syndrome
- MRI findings in two West Highland White Terrier dogs with hepatic encephalopathy secondary to portosystemic shunt
- Non-cirrhotic hyperammonaemia: are we missing the diagnosis?
- Diagnostic value of blood variables following attenuation of congenital extrahepatic portosystemic shunt in dogs
- Marked improvement in hyperammonaemic encephalopathy from multimodal treatment of metastatic neuroendocrine tumour